Matthew Hamilton Rosenberg’s Elevance Health ELV Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-25	Closed	-$10.9K	–	838
2025 Q1	$10.9K	Hold	25	–	–	﹤0.01%	620
2024 Q4	$9.22K	Sell	25 -134	-84%	-$56.1K	﹤0.01%	636
2024 Q3	$82.7K	Hold	159	–	–	0.02%	349
2024 Q2	$85K	Hold	159	–	–	0.03%	331
2024 Q1	$82K	Buy	159 +20	+14%	+$9.95K	0.02%	348
2023 Q4	$65.5K	Sell	139 -11	-7%	-$5.09K	0.02%	386
2023 Q3	$65.3K	Hold	150	–	–	0.02%	367
2023 Q2	$66.6K	Sell	150 -19	-11%	-$8.77K	0.02%	381
2023 Q1	$77.7K	Hold	169	–	–	0.03%	361
2022 Q4	$86.7K	Hold	169	–	–	0.03%	338
2022 Q3	$77K	Hold	169	–	–	0.03%	343
2022 Q2	$82K	Buy	169 +30	+22%	+$14.8K	0.03%	346
2022 Q1	$68K	Buy	139 +25	+22%	+$11.4K	0.02%	386
2021 Q4	$53K	Buy	+114	New	+$48K	0.02%	410

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Matthew Hamilton Rosenberg's ELV Position: Q2 2025 in Review

Matthew Hamilton Rosenberg sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 25 shares — an estimated $10.9K sold.

Matthew Hamilton Rosenberg first reported a position in ELV in Q4 2021 and held it in 14 quarters. The position peaked at $86.7K in Q4 2022. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

Matthew Hamilton Rosenberg reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
Matthew Hamilton Rosenberg sold 25 Elevance Health shares in Q2 2025, an estimated $10.9K.
Matthew Hamilton Rosenberg first reported a position in Elevance Health in Q4 2021 and held it in 14 quarters.
Matthew Hamilton Rosenberg's Elevance Health position peaked at $86.7K in Q4 2022.
1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Matthew Hamilton Rosenberg's 13F filing for Q2 2025, filed 28 Jul 2025.